{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:35:25Z","timestamp":1791297325245,"version":"4.1.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"17","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circulation"],"published-print":{"date-parts":[[2012,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background\u2014<\/jats:title>\n                    <jats:p>The rate of hospitalization for venous thromboembolism (VTE) is increasing in the United States. Although predictors of hospital-acquired VTE are well-known, triggers of VTE before hospitalization are not as clearly defined. The objective of this study was to evaluate triggers of hospitalization for VTE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and Results\u2014<\/jats:title>\n                    <jats:p>A case-crossover study was conducted. Subjects were participants in the Health and Retirement Study, a nationally representative sample of older Americans. Data were linked to Medicare files for hospital and nursing home stays, emergency department visits, outpatient visits including physician visits, and home health visits from years 1991 to 2007 (n=16 781). The outcome was hospitalization for venous thromboembolism (n=399). Exposures during the 90-day period before hospitalization for VTE were compared with exposures occurring in 4 comparison periods. Infection was the most common trigger of hospitalization for VTE, occurring in 52.4% of the risk periods before hospitalization. The adjusted incidence rate ratios (IRRs; 95% confidence interval) were 2.90 (2.13, 3.94) for all infection, 2.63 (1.90, 3.63) for infection without a previous hospital or skilled nursing facility stay, and 6.92 (4.46, 10.72) for infection with a previous hospital or skilled nursing facility stay. Erythropoiesis-stimulating agents and blood transfusion were also associated with VTE hospitalization (IRR=9.33, 95% confidence interval: 1.19, 73.42; IRR=2.57, 95% confidence interval: 1.17, 5.64; respectively). Other predictors included major surgeries, fractures (IRR=2.81), immobility (IRR=4.23), and chemotherapy (IRR=5.70). These predictors, combined, accounted for a large proportion (69.7%) of exposures before VTE hospitalization as opposed to 35.3% in the comparison periods.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions\u2014<\/jats:title>\n                    <jats:p>Risk prediction algorithms for VTE should be reevaluated to include infection, erythropoiesis-stimulating agents, and blood transfusion.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1161\/circulationaha.111.084467","type":"journal-article","created":{"date-parts":[[2012,4,4]],"date-time":"2012-04-04T01:45:30Z","timestamp":1333503930000},"page":"2092-2099","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":189,"title":["Triggers of Hospitalization for Venous Thromboembolism"],"prefix":"10.1161","volume":"125","author":[{"given":"Mary A.M.","family":"Rogers","sequence":"first","affiliation":[{"name":"From the Department of Internal Medicine, University of Michigan, Ann Arbor, MI (M.A.M.R., D.A.L., S.A.F., V.C., K.M.L.); Department of Pathology &amp; Laboratory Medicine, University of Rochester Medical Center, Rochester, NY (N.B.); HSR&amp;D Center for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System (D.A.L., K.M.L.); and Institute for Social Research, University of Michigan, Ann Arbor, MI (K.M.L.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah A.","family":"Levine","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine, University of Michigan, Ann Arbor, MI (M.A.M.R., D.A.L., S.A.F., V.C., K.M.L.); Department of Pathology &amp; Laboratory Medicine, University of Rochester Medical Center, Rochester, NY (N.B.); HSR&amp;D Center for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System (D.A.L., K.M.L.); and Institute for Social Research, University of Michigan, Ann Arbor, MI (K.M.L.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Blumberg","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine, University of Michigan, Ann Arbor, MI (M.A.M.R., D.A.L., S.A.F., V.C., K.M.L.); Department of Pathology &amp; Laboratory Medicine, University of Rochester Medical Center, Rochester, NY (N.B.); HSR&amp;D Center for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System (D.A.L., K.M.L.); and Institute for Social Research, University of Michigan, Ann Arbor, MI (K.M.L.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Flanders","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine, University of Michigan, Ann Arbor, MI (M.A.M.R., D.A.L., S.A.F., V.C., K.M.L.); Department of Pathology &amp; Laboratory Medicine, University of Rochester Medical Center, Rochester, NY (N.B.); HSR&amp;D Center for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System (D.A.L., K.M.L.); and Institute for Social Research, University of Michigan, Ann Arbor, MI (K.M.L.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vineet","family":"Chopra","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine, University of Michigan, Ann Arbor, MI (M.A.M.R., D.A.L., S.A.F., V.C., K.M.L.); Department of Pathology &amp; Laboratory Medicine, University of Rochester Medical Center, Rochester, NY (N.B.); HSR&amp;D Center for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System (D.A.L., K.M.L.); and Institute for Social Research, University of Michigan, Ann Arbor, MI (K.M.L.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth M.","family":"Langa","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine, University of Michigan, Ann Arbor, MI (M.A.M.R., D.A.L., S.A.F., V.C., K.M.L.); Department of Pathology &amp; Laboratory Medicine, University of Rochester Medical Center, Rochester, NY (N.B.); HSR&amp;D Center for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System (D.A.L., K.M.L.); and Institute for Social Research, University of Michigan, Ann Arbor, MI (K.M.L.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613830"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.2.172"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-1944"},{"key":"e_1_3_3_5_2","unstructured":"HCUP Databases. Healthcare Cost and Utilization Project (HCUP). Rockville MD: Agency for Healthcare Research and Quality; 2011. www.hcup-us.ahrq.gov\/nisoverview.jsp. Accessed November 11 2011."},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.968776"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a1227"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2011.04.004"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.publhealth.21.1.193"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a115853"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.2302"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.2307\/146277"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2010.03.009"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d4656"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.2.199"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.925214"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1067\/msy.2000.108224"},{"key":"e_1_3_3_18_2","unstructured":"Your Guide to Preventing and Treating Blood Clots. AHRQ Publication No. 09-0067-C. Rockville MD: Agency for Healthcare Research and Quality; May 2009. http:\/\/www.ahrq.gov\/consumer\/bloodclots.htm. Accessed November 12 2011."},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","unstructured":"Schmidt M Horvath-Puho E Thomsen RW Smeeth L S\u00f8rensen HT. Acute infections and venous thromboembolism. J Intern Med. October 25 2011. doi: 10.1111\/j.1365-2796.2011.02473.x. Available at: http:\/\/onlinelibrary.wiley.com. Accessed February 28 2012.","DOI":"10.1111\/j.1365-2796.2011.02473.x"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68474-2"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyr012"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.164.9.963"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.atv.0000166521.90532.44"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2004.06.028"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e328344c078"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e318225754f"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0410-381"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.168.21.2377"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2011.07.047"},{"key":"e_1_3_3_30_2","first-page":"CD002042","article-title":"Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion","volume":"10","author":"Carless PA","year":"2010","unstructured":"Carless PA, Henry DA, Carson JL, Hebert PP, McClelland B, Ker K. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev. 2010;10:CD002042.","journal-title":"Cochrane Database Syst Rev."},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.299.8.914"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp0912328"},{"key":"e_1_3_3_33_2","unstructured":"US Food and Drug Administration. Public Health Advisory: Erythropoiesis-Stimulating Agents (ESAs): Epoetin alfa (marketed as Procrit and Epogen) Darbepoetin alfa (marketed as Aranesp). November 8 2007. http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/DrugSafetyInformationforHeathcareProfessionals\/PublicHealthAdvisories\/ucm054716.htm. Accessed November 12 2011."},{"key":"e_1_3_3_34_2","unstructured":"US Food and Drug Administration. FDA Drug Safety Communication: Modified dosing recommendations to improve the safe use of Erythropoiesis-Stimulating Agents (ESAs) in chronic kidney disease. June 24 2011. http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm259639.htm. Accessed November 12 2011."},{"key":"e_1_3_3_35_2","article-title":"Top 200 drugs of 2010","author":"Bartholow M","unstructured":"Bartholow M. Top 200 drugs of 2010. Pharmacy Times. http:\/\/www.pharmacytimes.com\/publications\/issue\/2011\/May2011\/Top-200-Drugs-of-2010. Accessed November 12, 2011.","journal-title":"Pharmacy Times"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.34.5462"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c4245"}],"container-title":["Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCULATIONAHA.111.084467","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T02:46:40Z","timestamp":1715568400000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCULATIONAHA.111.084467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":36,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["10.1161\/CIRCULATIONAHA.111.084467"],"URL":"https:\/\/doi.org\/10.1161\/circulationaha.111.084467","relation":{},"ISSN":["0009-7322","1524-4539"],"issn-type":[{"value":"0009-7322","type":"print"},{"value":"1524-4539","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"2011-12-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-02-29","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-04-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}